echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Production Process of 8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine,gadolinium deriv.

    The Production Process of 8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine,gadolinium deriv.

    • Last Update: 2023-05-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine, gadolinium deriv.
    , also known as Gd-DOTA-Bn-Inamrinone, is an important intermediate in the production of contrast agents for magnetic resonance imaging (MRI).
    The compound is synthesized through a multi-step process that involves several chemical reactions.


    The production process of Gd-DOTA-Bn-Inamrinone can be broken down into the following steps:


    1. Synthesis of DOTA-Bn-Inamrinone
      The first step in the synthesis of Gd-DOTA-Bn-Inamrinone is the preparation of DOTA-Bn-Inamrinone.
      DOTA stands for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, which is a chelating agent that can bind to metal ions.
      Bn-Inamrinone is an organic compound that contains a nitroxide group, which is a stable radical that can be used as a precursor for the synthesis of Gd-DOTA-Bn-Inamrinone.

    The synthesis of DOTA-Bn-Inamrinone typically involves the following steps:


    • The preparation of DOTA by a series of chemical reactions, such as the condensation of o-phenylenediamine and benzene-1,4-diamine followed by the removal of the water molecule formed in the reaction.
    • The synthesis of Bn-Inamrinone, which involves the reduction of 4-nitro-1,2-benzenedicarboxylic acid diethyl ester to form Bn-Inamrinone.
    • The reaction of DOTA and Bn-Inamrinone in the presence of a suitable catalyst, such as sodium hydroxide, to form DOTA-Bn-Inamrinone.
    1. Complexation of Gd with DOTA-Bn-Inamrinone
      The next step in the synthesis of Gd-DOTA-Bn-Inamrinone is the complexation of Gd with DOTA-Bn-Inamrinone.
      Gd stands for gadolinium, a rare earth metal that is commonly used as a contrast agent in MRI.
      The complexation of Gd with DOTA-Bn-Inamrinone involves the formation of a stable complex between the gadolinium ion and the DOTA-Bn-Inamrinone molecule.

    The complexation of Gd with DOTA-Bn-Inamrinone typically involves the following steps:


    • The addition of a solution of Gd(NO3)2 in water to a solution of DOTA-Bn-Inamrinone in a suitable solvent, such as dimethylformamide or dimethyl sulfoxide.
    • The addition of a reducing agent, such as Na2S2O4, to the reaction mixture to reduce the Gd(III) ion to Gd(II) ion.
    • The reaction of the reduced Gd(II) ion with DOTA-Bn-Inamrinone to form the Gd-DOTA-Bn-Inamrinone complex.
    1. Purification of Gd-DOTA-Bn-Inamrinone
      The final step in the synthesis of Gd-DOTA-Bn-Inamrinone is the purification of the synthesized complex.
      The purification step is important to remove any impurities that may have been introduced during the previous steps.

    The purification of Gd-DOTA-Bn-Inamrinone typically involves the following steps:


    • The isolation of the Gd-DOTA-Bn-Inamrinone complex by column chromatography on a suitable stationary phase, such as silica gel or alumina.
    • The elution of the Gd-DOTA-Bn-Inamrinone complex from the column using a suitable el
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.